@article {4830,
	title = {Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade.},
	journal = {PloS one},
	volume = {10},
	year = {2015},
	month = {2015},
	pages = {e0135645},
	abstract = {New treatments for hepatitis C (HCV) infection hold great promise for cure, but numerous challenges to diagnosing, establishing care, and receiving therapy exist. There are limited data on insurance authorization for these medications.},
	issn = {1932-6203},
	doi = {10.1371/journal.pone.0135645},
	author = {Do, Albert and Mittal, Yash and Liapakis, AnnMarie and Cohen, Elizabeth and Chau, Hong and Bertuccio, Claudia and Sapir, Dana and Wright, Jessica and Eggers, Carol and Drozd, Kristine and Ciarleglio, Maria and Deng, Yanhong and Lim, Joseph K}
}
